| 发明名称 |
Pharmaceutical formulations containing darifenacin |
| 摘要 |
<p>The invention provides an oral tablet formulation consisting essentially of darifenacin hydrobromide in a high molecular weight hydroxypropyl methylcellulose matrix together with anhydrous dibasic calcium phosphate and magnesium stearate.</p> |
| 申请公布号 |
EP1245231(B1) |
申请公布日期 |
2004.06.16 |
| 申请号 |
EP20020015165 |
申请日期 |
1996.08.21 |
| 申请人 |
NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. |
发明人 |
DOLAN, THOMAS FRANCIS;HUMPHREY, MICHAEL JOHN;NICHOLS, DONALD JOHN |
| 分类号 |
A61K9/22;A61K9/02;A61K9/16;A61K9/20;A61K9/50;A61K31/40;A61K31/4025;A61K47/38;A61K47/48;A61P1/00;A61P1/12;A61P13/02;A61P15/00;A61P31/00;C07D405/06;(IPC1-7):A61K31/402 |
主分类号 |
A61K9/22 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
